By Dominic Bernard2026-09-25T12:30:00
The popularisation of GLP-1 weight-loss drugs has driven a rebound in M&A in snacking companies around the world, according to analysis by investment bank Houlihan Lokey
The popularisation of GLP-1 weight-loss drugs has driven a rebound in M&A in snacking companies around the world, according to analysis by investment bank Houlihan Lokey.
Already have an account? Sign in here
Already have an account? Sign in here